The objective of this proposal is to continue participation in the ACTG by (1) evaluating the safety and efficacy of therapeutic interventions for the treatment of Human Immunodeficiency Virus (HIV) infection, Acquired Immunodeficiency Syndrome (AIDS) and associated conditions, (2) generating and publishing data, (3) submitting concept sheets and (4) participating in the committee system of the ACTG. Part A, the Adult ACTU (Clinical Core), will maintain an infrastructure to accrue new patients in protocols, complete existing protocols, and provide protocol mandated immunophenotyping. Expertise is available in Infectious Diseases, Oncology, Neurology and Ophthalmology. Special attention will be given to the inclusion of women and minorities. The resources of the core will be made available to other investigators whose research is committed to promoting the treatment and prevention of HIV infection. Subproject 9004; the Pediatric Component, will enroll children and pregnant women in protocols and complete existing protocols. Expertise is available in Pediatrics, Obstetrics/Gynecology and Perinatal Medicine. HIV-infected family members will be included by integrating efforts with the Adult Clinical Core. Subproject 9005; Protocol Mandated Virology, will utilize conventional and sate-of-the-art techniques to meet protocol requirements. Included will be measurement of p24 antigen levels, culture of HIV from clinical samples and measurement of other viral or surrogate markers. Subproject 5, Developmental Research in Immunology, will characterize immunologic function in HIV-infection. HIV-specific immune responsiveness will be quantitatively assessed in seropositive and seronegative couples and in vaccinated individuals using synthetic peptides. Subproject 6, Other Microbiological Developmental Research, well perform retrospective and prospective studies to determine if there is a correlation between reactivation and/or perpetuation of HSV infection and the clinical course of HIV infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI025924-08
Application #
2063184
Study Section
Special Emphasis Panel (SRC (61))
Project Start
1987-09-30
Project End
1996-01-31
Budget Start
1994-02-01
Budget End
1995-01-31
Support Year
8
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Ohio State University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Brashers, Dale E; Basinger, Erin D; Rintamaki, Lance S et al. (2017) Taking Control: The Efficacy and Durability of a Peer-Led Uncertainty Management Intervention for People Recently Diagnosed With HIV. Health Commun 32:11-21
Peterson, Jennifer L; Rintamaki, Lance S; Brashers, Dale E et al. (2012) The forms and functions of peer social support for people living with HIV. J Assoc Nurses AIDS Care 23:294-305
Winham, Stacey J; Slater, Andrew J; Motsinger-Reif, Alison A (2010) A comparison of internal validation techniques for multifactor dimensionality reduction. BMC Bioinformatics 11:394
Raboud, Janet M; Diong, Christina; Carr, Andrew et al. (2010) A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy. HIV Clin Trials 11:39-50
Williams, Pl; Wu, Jw; Cohn, Se et al. (2009) Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution. HIV Med 10:290-301
Skowron, Gail; Spritzler, John G; Weidler, Jodi et al. (2009) Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects. J Acquir Immune Defic Syndr 50:250-8
Sax, Paul E; Tierney, Camlin; Collier, Ann C et al. (2009) Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy. N Engl J Med 361:2230-40
Ma, Qing; Forrest, Alan; Rosenkranz, Susan L et al. (2008) Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharm Drug Dispos 29:91-101
Collier, Ann C; Tierney, Camlin; Downey, Gerald F et al. (2008) Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV. HIV Clin Trials 9:91-102
Demeter, Lisa M; DeGruttola, Victor; Lustgarten, Stephanie et al. (2008) Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience. HIV Clin Trials 9:11-25

Showing the most recent 10 out of 97 publications